Exelixis Inc (NASDAQ: EXEL) on Friday, plunged -1.65% from the previous trading day, before settling in for the closing price of $42.35. Within the past 52 weeks, EXEL’s price has moved between $31.90 and $49.62.
Healthcare Sector giant saw their annual sales surged by 11.55% over the last five years. The company achieved an average annual earnings per share of 65.12%. With a float of $259.25 million, this company’s outstanding shares have now reached $268.10 million.
Exelixis Inc (EXEL) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Exelixis Inc is 3.31%, while institutional ownership is 95.80%. The most recent insider transaction that took place on Nov 12 ’25, was worth 4,355,000. In this transaction Director of this company sold 100,000 shares at a rate of $43.55, taking the stock ownership to the 1,189,228 shares. Before that another transaction happened on Nov 11 ’25, when Company’s EVP, Research and Development sold 48,383 for $42.50, making the entire transaction worth $2,056,278. This insider now owns 664,778 shares in total.
Exelixis Inc (EXEL) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.55 earnings per share (EPS) for the period topping the consensus outlook (set at 0.49) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 65.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.57% during the next five years compared to 11.55% growth over the previous five years of trading.
Exelixis Inc (NASDAQ: EXEL) Trading Performance Indicators
Exelixis Inc (EXEL) is currently performing well based on its current performance indicators. A quick ratio of 3.68 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.88. Likewise, its price to free cash flow for the trailing twelve months is 14.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.38, a number that is poised to hit 0.76 in the next quarter and is forecasted to reach 3.23 in one year’s time.
Technical Analysis of Exelixis Inc (EXEL)
Analysing the last 5-days average volume posted by the [Exelixis Inc, EXEL], we can find that recorded value of 2.72 million was lower than the volume posted last year of 2.96 million. As of the previous 9 days, the stock’s Stochastic %D was 82.46%.
During the past 100 days, Exelixis Inc’s (EXEL) raw stochastic average was set at 52.69%, which indicates a significant decrease from 73.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.44 in the past 14 days, which was higher than the 1.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.47, while its 200-day Moving Average is $39.20. Now, the first resistance to watch is $42.42. This is followed by the second major resistance level at $43.18. The third major resistance level sits at $43.78. If the price goes on to break the first support level at $41.06, it is likely to go to the next support level at $40.46. Now, if the price goes above the second support level, the third support stands at $39.70.
Exelixis Inc (NASDAQ: EXEL) Key Stats
Market capitalization of the company is 11.17 billion based on 268,112K outstanding shares. Right now, sales total 2,169 M and income totals 521,270 K. The company made 597,760 K in profit during its latest quarter, and 193,580 K in sales during its previous quarter.
